Kiora PharmaceuticalsKPRX
13F holders, Q1 2025 (March 31)18holders +2
3new positions
1sold out
1famous investor
$3.01avg. 13F price*
At the end of Q1 2025, 18 institutions reported holding Kiora Pharmaceuticals Inc. (KPRX) in their 13F filings, up 2 from Q4 2024. 3 opened new positions and 1 sold out. The largest holders were AIGH Capital Management LLC ($763K), Rosalind Advisors, Inc. ($753K) and Nantahala Capital Management, LLC ($635K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Kiora Pharmaceuticals Inc.
- CUSIP
- 49721T507
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $97K |
| Exits | 1 | $26 |
All 13F filers, Q4 2024 → Q1 2025: 35,875 shares bought and 9,931 shares sold, net +25,944 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| AIGH Capital Management LLC | 0.40% | Reduce -0.8% | 253,555 | $763K |
| Rosalind Advisors, Inc. | 0.37% | Reduce -0.2% | 250,059 | $753K |
| Nantahala Capital Management, LLC | 0.05% | No change | 211,110 | $635K |
| Stonepine Capital Management, LLC | 0.59% | Reduce -0.2% | 200,647 | $604K |
| ADAR1 Capital Management, LLC | 0.12% | Reduce -2.8% | 194,665 | $586K |
| Velan Capital Investment Management LP | 0.38% | No change | 122,223 | $368K |
| Citadel Advisors | 0.00% | New | 26,550 | $80K |
| Geode Capital Management, LLC | 0.00% | Add +15.0% | 18,347 | $55K |
| Sabby Management, LLC | 0.06% | New | 5,000 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +81.3% | 2,185 | $7K |
| Morgan Stanley | 0.00% | New | 700 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +25500.0% | 256 | $771 |
| BlackRock, Inc. | 0.00% | Reduce -96.4% | 58 | $175 |
| NewEdge Advisors, LLC | 0.00% | No change | 22 | $66 |
| Bank of America Corp. | 0.00% | No change | 20 | $60 |
| UBS Group AG | 0.00% | No change | 2 | $6 |
| Osaic Holdings, Inc. | 0.00% | No change | 2 | $6 |
| Activest Wealth Management | 0.00% | No change | 2 | $6 |
"% of holder's portfolio" is KPRX's weight in each manager's 13F, not the share of Kiora Pharmaceuticals Inc. the manager owns.